Literature DB >> 17531221

Diseases of epidermal keratins and their linker proteins.

Jouni Uitto1, Gabriele Richard, John A McGrath.   

Abstract

Epidermal keratins, a diverse group of structural proteins, form intermediate filament networks responsible for the structural integrity of keratinocytes. The networks extend from the nucleus of the epidermal cells to the plasma membrane where the keratins attach to linker proteins which are part of desmosomal and hemidesmosomal attachment complexes. The expression of specific keratin genes is regulated by differentiation of the epidermal cells within the stratifying squamous epithelium. Progress in molecular characterization of the epidermal keratins and their linker proteins has formed the basis to identify mutations which are associated with distinct cutaneous manifestations in patients with genodermatoses. The precise phenotype of each disease apparently reflects the spatial level of expression of the mutated genes, as well as the types and positions of the mutations and their consequences at mRNA and protein levels. Identification of specific mutations in keratinization disorders has provided the basis for improved diagnosis and subclassification with prognostic implications and has formed the platform for prenatal testing and preimplantation genetic diagnosis. Finally, precise knowledge of the mutations is a prerequisite for development of gene therapy approaches to counteract, and potentially cure, these often devastating and currently intractable diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17531221      PMCID: PMC2578874          DOI: 10.1016/j.yexcr.2007.03.029

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  93 in total

1.  Clinical and molecular significance of splice site mutations in the plakophilin 1 gene in patients with ectodermal dysplasia-skin fragility syndrome.

Authors:  Vesarat Wessagowit; John A McGrath
Journal:  Acta Derm Venereol       Date:  2005       Impact factor: 4.437

Review 2.  Genetic diseases of junctions.

Authors:  Joey E Lai-Cheong; Ken Arita; John A McGrath
Journal:  J Invest Dermatol       Date:  2007-12       Impact factor: 8.551

Review 3.  Progress in epidermolysis bullosa: the phenotypic spectrum of plectin mutations.

Authors:  E Pfendner; F Rouan; J Uitto
Journal:  Exp Dermatol       Date:  2005-04       Impact factor: 3.960

Review 4.  Hemidesmosomal variants of epidermolysis bullosa. Mutations in the alpha6beta4 integrin and the 180-kD bullous pemphigoid antigen/type XVII collagen genes.

Authors:  L Pulkkinen; J Uitto
Journal:  Exp Dermatol       Date:  1998 Apr-Jun       Impact factor: 3.960

5.  Homozygous nonsense mutation in helix 2 of K14 causes severe recessive epidermolysis bullosa simplex.

Authors:  L D Corden; J E Mellerio; M J Gratian; R A Eady; J I Harper; M Lacour; G Magee; E B Lane; J A McGrath; W H McLean
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

6.  Diffuse nonepidermolytic palmoplantar keratoderma caused by a recurrent nonsense mutation in DSG1.

Authors:  Hannah Keren; Reuven Bergman; Mordechai Mizrachi; Yechiezkel Kashi; Eli Sprecher
Journal:  Arch Dermatol       Date:  2005-05

Review 7.  Ichthyosis bullosa of Siemens: its correct diagnosis facilitated by molecular genetic testing.

Authors:  M Akiyama; Y Tsuji-Abe; M Yanagihara; K Nakajima; H Kodama; M Yaosaka; M Abe; D Sawamura; H Shimizu
Journal:  Br J Dermatol       Date:  2005-06       Impact factor: 9.302

8.  Haploinsufficiency of desmoplakin causes a striate subtype of palmoplantar keratoderma.

Authors:  D K Armstrong; K E McKenna; P E Purkis; K J Green; R A Eady; I M Leigh; A E Hughes
Journal:  Hum Mol Genet       Date:  1999-01       Impact factor: 6.150

9.  Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2.

Authors:  S P Covello; F J Smith; J H Sillevis Smitt; A S Paller; C S Munro; M F Jonkman; J Uitto; W H McLean
Journal:  Br J Dermatol       Date:  1998-09       Impact factor: 9.302

Review 10.  Role of plectin in cytoskeleton organization and dynamics.

Authors:  G Wiche
Journal:  J Cell Sci       Date:  1998-09       Impact factor: 5.285

View more
  24 in total

Review 1.  Anchoring junctions as drug targets: role in contraceptive development.

Authors:  Dolores D Mruk; Bruno Silvestrini; C Yan Cheng
Journal:  Pharmacol Rev       Date:  2008-05-15       Impact factor: 25.468

2.  Keratinization and its disorders.

Authors:  Shibani Shetty
Journal:  Oman Med J       Date:  2012-09

3.  Therapeutic potential of a non-steroidal bifunctional anti-inflammatory and anti-cholinergic agent against skin injury induced by sulfur mustard.

Authors:  Yoke-Chen Chang; James D Wang; Rita A Hahn; Marion K Gordon; Laurie B Joseph; Diane E Heck; Ned D Heindel; Sherri C Young; Patrick J Sinko; Robert P Casillas; Jeffrey D Laskin; Debra L Laskin; Donald R Gerecke
Journal:  Toxicol Appl Pharmacol       Date:  2014-08-13       Impact factor: 4.219

4.  Loss of keratin K2 expression causes aberrant aggregation of K10, hyperkeratosis, and inflammation.

Authors:  Heinz Fischer; Lutz Langbein; Julia Reichelt; Silke Praetzel-Wunder; Maria Buchberger; Minoo Ghannadan; Erwin Tschachler; Leopold Eckhart
Journal:  J Invest Dermatol       Date:  2014-04-21       Impact factor: 8.551

Review 5.  Keratin gene mutations in disorders of human skin and its appendages.

Authors:  Jean Christopher Chamcheu; Imtiaz A Siddiqui; Deeba N Syed; Vaqar M Adhami; Mirjana Liovic; Hasan Mukhtar
Journal:  Arch Biochem Biophys       Date:  2010-12-19       Impact factor: 4.013

6.  Keratin overexpression levels correlate with the extent of spontaneous pancreatic injury.

Authors:  Diana M Toivola; Ikuo Nakamichi; Pavel Strnad; Sara A Michie; Nafisa Ghori; Masaru Harada; Karin Zeh; Robert G Oshima; Helene Baribault; M Bishr Omary
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

7.  Desmosomes in vivo.

Authors:  David Garrod
Journal:  Dermatol Res Pract       Date:  2010-06-24

8.  Characterization of in vivo keratin 19 phosphorylation on tyrosine-391.

Authors:  Qin Zhou; Natasha T Snider; Jian Liao; Daniel H Li; Anita Hong; Nam-On Ku; Christine A Cartwright; M Bishr Omary
Journal:  PLoS One       Date:  2010-10-25       Impact factor: 3.240

9.  New common variants affecting susceptibility to basal cell carcinoma.

Authors:  Simon N Stacey; Patrick Sulem; Gisli Masson; Sigurjon A Gudjonsson; Gudmar Thorleifsson; Margret Jakobsdottir; Asgeir Sigurdsson; Daniel F Gudbjartsson; Bardur Sigurgeirsson; Kristrun R Benediktsdottir; Kristin Thorisdottir; Rafn Ragnarsson; Dominique Scherer; Kari Hemminki; Peter Rudnai; Eugene Gurzau; Kvetoslava Koppova; Rafael Botella-Estrada; Virtudes Soriano; Pablo Juberias; Berta Saez; Yolanda Gilaberte; Victoria Fuentelsaz; Cristina Corredera; Matilde Grasa; Veronica Höiom; Annika Lindblom; Johannes J Bonenkamp; Michelle M van Rossum; Katja K H Aben; Esther de Vries; Mario Santinami; Maria G Di Mauro; Andrea Maurichi; Judith Wendt; Pia Hochleitner; Hubert Pehamberger; Julius Gudmundsson; Droplaug N Magnusdottir; Solveig Gretarsdottir; Hilma Holm; Valgerdur Steinthorsdottir; Michael L Frigge; Thorarinn Blondal; Jona Saemundsdottir; Hjördis Bjarnason; Kristleifur Kristjansson; Gyda Bjornsdottir; Ichiro Okamoto; Licia Rivoltini; Monica Rodolfo; Lambertus A Kiemeney; Johan Hansson; Eduardo Nagore; José I Mayordomo; Rajiv Kumar; Margaret R Karagas; Heather H Nelson; Jeffrey R Gulcher; Thorunn Rafnar; Unnur Thorsteinsdottir; Jon H Olafsson; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2009-07-05       Impact factor: 38.330

10.  Nonsense mutations in AAGAB cause punctate palmoplantar keratoderma type Buschke-Fischer-Brauer.

Authors:  Kathrin A Giehl; Gertrud N Eckstein; Sandra M Pasternack; Silke Praetzel-Wunder; Thomas Ruzicka; Peter Lichtner; Kerstin Seidl; Mike Rogers; Elisabeth Graf; Lutz Langbein; Markus Braun-Falco; Regina C Betz; Tim M Strom
Journal:  Am J Hum Genet       Date:  2012-09-20       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.